Furthermore, in the established xenograft mouse model, we used liposome-capsuled TRAIL-expressing plasmid to perform a multipoint injection on tumor tissues in miR-137-overexpressed or control xenografts. This evidence concerns the gene TNFSF10 and neoplasm.